Form 8-K - Current report:
SEC Accession No. 0001401708-24-000019
Filing Date
2024-02-08
Accepted
2024-02-08 10:45:26
Documents
15
Period of Report
2024-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nstg-20240205.htm   iXBRL 8-K 43663
2 EX-10.1 nanostring-dipcreditagreem.htm EX-10.1 1114055
  Complete submission text file 0001401708-24-000019.txt   1482777

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nstg-20240205.xsd EX-101.SCH 1948
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nstg-20240205_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nstg-20240205_pre.xml EX-101.PRE 12550
16 EXTRACTED XBRL INSTANCE DOCUMENT nstg-20240205_htm.xml XML 2728
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Filer) CIK: 0001401708 (see all company filings)

EIN.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35980 | Film No.: 24607519
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)